Navigation Links
3rd international conference on innovative approaches in head and neck oncology
Date:2/1/2011

The European Society for Therapeutic Radiology and Oncology (ESTRO), the European Head and Neck Society (EHNS), and the European Society for Medical Oncology (ESMO) in collaboration with other European partners, have the pleasure of inviting you to report on the 3rd International Conference on innovative approaches In Head and Neck Oncology.

With major emphasis on multidisciplinarity and innovation, this meeting will specifically cover the main following topics:

  • Biological patient profiling and risk factors
  • Emerging diagnostic and therapeutic tools
  • Functional outcome of treatments
  • Global care of patients (cultural issues, psychosocial support, what do patients expect, etc)
  • Clinical controversies based on case discussions such as Evidence-based medicine or practice based medicine, etc

More information on the conference: http://www.estro-events.org/Pages/ichno2011.aspx

More information on Head & Neck cancers on the Radiotherapy Information Centre: http://www.estro-ric.org/media/Pages/HeadandNeckCancer.aspx#Head%20&%20Neck%20cancers

Tremendous achievements in Head & Neck cancers

Head and neck cancers together make up 5% of all cancers diagnosed each year 120,000(1) across Europe. The most common head and neck cancers are:

  • the mouth and tongue (oral cavity)
  • the back of the throat (pharynx)
  • the voice box (larynx)
  • the sinuses

Oral cancers represent 3% of new cases in the UK and 6% in France; while in Sri Lanka, India, Pakistan and Bangladesh, oral cancer is the most common cancer in men and may account for up to 30% of all new cases of cancer (2).

But over the last decade, tremendous achievements have been made in the management of patients with Head & Neck Cancer. Advancements in the understanding of the pathogenesis of Head & Neck malignancies could rapidly lead to the elaboration of tailored treatments:

  • Functional imaging has emerged as a complementary modality to anatomic imaging methods for better staging,
  • Treatment response evaluation and optimal treatment targeting are evolving,
  • Surgery has improved markedly, in particular with better reconstruction techniques moving the limit of operability further.
  • Randomised studies have demonstrated the increasing role of combined modality approaches with chemotherapy and biological targeted therapies.
  • New radiation techniques, expected to impact on survival and quality of life of Head & Neck patients, have taken off the ground

And this is just the beginning, with many more challenges ahead of us.

(1,2) Source: European Society for Therapeutic Radiology and Oncology (ESTRO) 2008, www.estro-ric.org

Media registration

You can pre-register now by writing to cecile.hardon@estro.org. On-site registration is possible at the Press Registration Desk. You will be asked for your press card and a letter of assignment.


'/>"/>

Contact: Cecile Hardon-Villard
cecile.hardon@estro.org
322-775-9340
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Lung societies unveil new international classification of lung adenocarcinoma
2. American Chemical Society unveils International Year of Chemistry virtual journal
3. International community called upon to stop the runaway train of cancer in Africa
4. Biodesign hosts international consortium on screening for lung cancer
5. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
6. International research team reports major findings in prevention and treatment of blood clots
7. International consortium to examine the impact of medical devices on health and retirement
8. New international conference in bionic engineering
9. International clinical trial tests targeted drug for melanoma
10. Experts present new testing methods at international meeting in New Orleans, Nov. 14-18
11. Half of those travelling internationally not aware of potential health risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , ... February 24, 2017 , ... The narrative in ... Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes the tragedies ... and his attempts to overcome them. , Schanssema, initially unsure of the career ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of ... “Imagine Me Beyond What You See” body image mannequin art competition. Selected from 15 ... showcased and the winner revealed at the 31st annual iaedp Symposium, March 22 – ...
(Date:2/24/2017)... ... 2017 , ... Congratulations to Head Over Heels’ elite gymnast ... Ms. Esparza qualified into this prestigious status after winning the Vault, Floor, ... Nevada. Frida is one of approximately 25 gymnasts in the nation who earns ...
(Date:2/23/2017)... ... ... The 89th Academy Awards will be celebrated this weekend, which means it’s also ... We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the shoddiest think ... American Progress (CAP), for its report, Lessons From State Performance on NAEP: Why Some ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Los Angeles-based ... episodes of WE TV’s “Mama June: From Not to Hot,” which will begin airing ... “Mama” June Shannon, known to millions from the 2012 reality television series, “Here Comes ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die Guian ... Provinz Guizhou, 2017 mit dem Angebot von Anreize schaffenden Strategien ... einer eingebetteten Hightech-Schlüsselindustrie. Foto - http://mma.prnewswire.com/media/471342/First_CRH__CHina_Railway_High_Speed__Train_Enters_Guian.jpg ... ... ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Fibromyalgia ... offering. ... latest research Fibromyalgia Drugs Price Analysis and Strategies - 2016, provides ... The research answers the following questions: ... attributes? How are they positioned in the Global Fibromyalgia market? ...
(Date:2/23/2017)... Feb. 23, 2017 Regulus Therapeutics Inc ... and development of innovative medicines targeting microRNAs, today announced ... financial results on Thursday, March 2, 2017 after the ... call and webcast on March 2, 2017 at 5:00 ... year 2016 financial results and provide a general business ...
Breaking Medicine Technology: